1. Introduction 1.1 Market Definition 2. Research Methodology 3. Executive Summary 4. Key Inferences 5. Market Overview 5.1 Current Market Scenario 5.2 Porter's Five Forces Analysis 5.2.1 Bargaining Power of Suppliers 5.2.2 Bargaining Power of Consumers 5.2.3 Threat of New Entrants 5.2.4 Threat of Substitute Product and Services 5.2.5 Competitive Rivalry within the Industry 6. Market Dynamics 6.1 Drivers 6.1.1 Rising Adoption of Biologics and Increasing R&D on Regenerative Medicines 6.1.2 Rising Prevalence of Gout with Increasing Alcohol Consumption 6.1.3 Technological Advancements in Imaging Modalities Improved Understanding of Gout 6.2 Restraints 6.2.1 Side Effects of Gout Therapeutic Drugs 6.2.2 High Indirect Costs of Gout Therapeutics 6.3 Opportunities 6.4 Key Challenges 7. Market Segmentation 7.1 By Drug Class 7.1.1 NSAIDs 7.1.2 Corticosteroids 7.1.3 Colchicine 7.1.4 Urate-Lowering Agents 7.2 By Application 7.2.1 Acute Gout 7.2.2 Chronic Gout 7.3 By Geography 7.3.1 North America 7.3.1.1 US 7.3.1.2 Canada 7.3.1.3 Mexico 7.3.2 Europe 7.3.2.1 France 7.3.2.2 Germany 7.3.2.3 UK 7.3.2.4 Italy 7.3.2.5 Spain 7.3.2.6 Rest of Europe 7.3.3 Asia-Pacific 7.3.3.1 China 7.3.3.2 Japan 7.3.3.3 India 7.3.3.4 Australia 7.3.3.5 South Korea 7.3.3.6 Rest of Asia-Pacific 7.3.4 Middle East & Africa 7.3.4.1 GCC 7.3.4.2 South Africa 7.3.4.3 Rest of MEA 7.3.5 South America 7.3.5.1 Brazil 7.3.5.2 Argentina 7.3.5.3 Rest of South America 8. Competitive Landscape 8.1 Mergers & Acquisition Analysis 8.2 Agreements, Collaborations, and Partnerships 8.3 New Products Launches 9. Key Players 9.1 AstraZeneca PLC 9.2 Boehringer Ingelheim 9.2 GlaxoSmithKline PLC 9.4 Horizon Pharma PLC 9.5 Merck & Co. Inc 9.6 Novartis AG 9.7 Regeneron Pharmaceuticals 9.8 Savient Pharmaceuticals 9.9 Takeda Pharmaceutical Company Ltd. 9.10 Teijin Pharma Ltd * List Not Exhaustive 10. Future of the Market

AstraZeneca plc, Boehringer Ingelheim, GlaxoSmithKline plc, Horizon Pharma plc, Merck & Co. Inc, Novartis, Regeneron Pharmaceuticals, Savient Pharmaceuticals, Takeda Pharmaceutical Company Ltd., and Teijin Pharma Ltd, among others.